Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review …

M Tagliamento, E Agostinetto, M Bruzzone… - Critical reviews in …, 2021 - Elsevier
Background A systematic review and meta-analysis was performed to estimate mortality in
adult patients with solid or hematological malignancies and SARS-CoV-2 infection. Methods …

Mortality in cancer patients with COVID-19 who are admitted to an ICU or who have severe COVID-19: a systematic review and meta-analysis

AR Nadkarni, SC Vijayakumaran, S Gupta… - JCO Global …, 2021 - ascopubs.org
PURPOSE There are scarce data to aid in prognostication of the outcome of critically ill
cancer patients with COVID-19. In this systematic review and meta-analysis, we investigated …

[HTML][HTML] Outcomes of COVID-19 and risk factors in patients with cancer

M Sengar, G Chinnaswamy, P Ranganathan, A Ashok… - Nature Cancer, 2022 - nature.com
Patients with cancer are at higher risk for adverse coronavirus disease 2019 (COVID-19)
outcomes. Here, we studied 1,253 patients with cancer, who were diagnosed with severe …

[HTML][HTML] The global impact of COVID-19 on childhood cancer outcomes and care delivery-a systematic review

A Majeed, T Wright, B Guo, RS Arora, CG Lam… - Frontiers in …, 2022 - frontiersin.org
Background: Childhood cancer represents a leading cause of death and disease burden in
high income countries (HICs) and low-and-middle income countries (LMICs). It is postulated …

Impact of COVID-19 on outcomes for patients with cervical cancer in India

N Gupta, AS Chauhan, S Prinja, AK Pandey - JCO Global Oncology, 2021 - ascopubs.org
PURPOSE The COVID-19 pandemic has placed unprecedented demands on the health
system. This led to delays in the initiation and completion of cancer treatment. We assessed …

[HTML][HTML] COVID-19 mortality in cancer patients: a report from a tertiary cancer centre in India

A Mehta, S Vasudevan, A Parkash, A Sharma… - PeerJ, 2021 - peerj.com
Background Cancer patients, especially those receiving cytotoxic therapy, are assumed to
have a higher probability of death from COVID-19. We have conducted this study to identify …

Professional challenges for United States hematology/oncology trainees during COVID-19

R Banerjee, SA Kareff, Y Leyfman, N Dhawan… - Cancer …, 2023 - Taylor & Francis
COVID-19 has been devastating for patients with cancer. In this commentary, we chronicle
the pandemic's downstream impacts on United States hematology/oncology trainees in …

[HTML][HTML] Clinical considerations for critically ill COVID-19 cancer patients: A systematic review

C Ramasamy, AK Mishra, KJ John… - World Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
BACKGROUND The World Health Organization (WHO) on March 11, 2020, had declared
the novel coronavirus disease 2019 (COVID-19) outbreak a global pandemic. The COVID …

Impact of COVID-19 pandemic on the oncologic care continuum: urgent need to restore patients care to pre-COVID-19 era

E Osei, R Francis, A Mohamed, L Sheraz… - … of Radiotherapy in …, 2023 - cambridge.org
Background: Globally, cancer is the second leading cause of death, and it is estimated that
over 18· 1 million new cases are diagnosed annually. The COVID-19 pandemic has …

[HTML][HTML] Clinical profile and short-term outcome of children with acute SARS-CoV-2 infection during the first and second waves of the pandemic

S Muthusamy, B Sarojam, S Sugunan… - Indian Journal of …, 2023 - Springer
Objectives To compare the clinical profile and short-term outcome of children admitted with
acute SARS-CoV-2 infection during the first and second waves of the Coronavirus Disease …